For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Mérida 97138

0 studies enrolling now · 10 studies all time

What they study most

Autoimmune Disease, Axial Spondyloarthritis, Connective Tissue Disease, Diabetes Mellitus, Type 2, Diabetic Kidney Disease, Gastroesophageal Junction Adenocarcinoma, Head and Neck Cancer, Major Depressive Disorder, Metastatic Gastric Adenocarcinoma, Migraine, Rheumatoid Arthritis, Spondyloarthritis

Studies at this site

• A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer — Completed
• A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis — Completed
• Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study — Completed
• A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis — Completed
• A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease — Completed
• A Study in Head and Neck Cancer — Completed
• A Study in Moderate to Severe Rheumatoid Arthritis — Completed
• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus — Completed
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4) — Completed
• A Study in the Treatment of Children and Adolescents With Major Depressive Disorder — Completed